<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=192888919167017&amp;ev=PageView&amp;noscript=1">
Thursday, March 28, 2024
March 28, 2024

Linkedin Pinterest

Breast cancer patients sought for drug study

The Columbian
Published: August 3, 2010, 12:00am

Breast cancer patients are being sought for a Legacy Health study on whether Vitamin E and Trental (a drug used to improve blood flow) can lessen complication rates when radiation is used in conjunction with breast implant reconstruction.

Brian Willoughby, spokesman for Salmon Creek Medical Center, said women 18 and older are candidates if they have had a mastectomy with expander or implant reconstruction after a diagnosis of breast cancer and are receiving or have recently completed radiation therapy.

Participation in the study will begin within two weeks of completing radiation treatment and last a total of 18 months.

If you are interested in learning more about this study, call Legacy Salmon Creek Medical Center at 360-487-1000 and ask to be transferred to Cancer Research at Legacy Good Samaritan. Participants can receive treatment at Legacy Salmon Creek Medical Center in Vancouver, Legacy Good Samaritan Medical Center in Portland or Legacy Mount Hood Medical Center in Gresham.

Loading...